Methods and uses of leptin in hepatocellular carcinoma
The present invention relates to methods for the modulation of immune responses. More particularly, the invention relates to methods and uses of leptin for immuno-modulation of the balance between the Th1/Th2 responses and for the treatment of immune-related disorders. Specifically, the methods of the invention comprise shifting the Th1/Th2 cell balance towards the proinflammatory state. This modulation of the cell balance may be performed by increasing the activity and/or the expression of leptin in said subject, for instance by raising the amount of leptin. The amount of leptin in a subject may be increased by activating immunoregulatory cells, administering an immunomodulatory amount of leptin or a homologue, derivative, or functional fragment of leptin.
1. A method of treating cancer or an immune disorder caused by immune suppression in a subject comprising administration of a reagent that increases the activity of leptin in said subject wherein a shift takes place in the Th1/Th2 balance towards a pro-inflammatory state, wherein said cancer or said immune disorder is Hepatocellular carcinoma (HCC).
2. A method for the treatment of an immune-related disorder in a subject comprising increasing the activity of leptin in said subject by administering to said subject an immunomodulatory amount of leptin, any functional homologue, functional derivative, or functional fragment of leptin, or any combination of any of the foregoing, wherein said immune-related disorder is Hepatocellular carcinoma (HCC).
3. The method of claim 1 wherein increasing the activity in said subject comprises raising the amount of leptin in said subject.
4. The method of claim 3 wherein said increase in leptin amount is caused by administering to said subject an immunomodulatory amount of leptin, any functional homologue, functional derivative, or functional fragment of leptin, or any combination of any of the foregoing.